期刊文献+

TCD结合屏气试验评价 Hhcy者脑血管反应性 被引量:1

The evaluation of cerebrovascular reactivity by TCD combined with breath holding test
下载PDF
导出
摘要 目的:评价高同型半胱氨酸血症者脑血管反应性.方法:高同型半胱氨酸血症者42例(年龄23~65岁,男24例,女18例),正常人群50例(年龄20~68岁,男29例,女21例),两组间年龄差异及性别比例无统计学意义.嘱托受试者平静呼吸5~10min后屏气25s,分别记录屏气前后MCA平均血流速度Vm及搏动指数PI值.并计算其变化值及变化率.结果:高同型半胱氨酸血症组平均血流速度Vm较对照组增快(P<0.01),搏动指数PI高于对照组(P<0.05).高同型半胱氨酸血症者组平均血流速度Vm变率为低于对照组,差异有统计学意义(P<0.01).结论:①高同型半胱氨酸血症者脑血管反应性降低.②TCD检查可以为高同型半胱氨酸血症者早期防治提供理论依据. Objective. To evaluate hyperhomocysteinemia cerebral vascular reactivity. Methods. There were 42 cases in Hyper homocysteinemia group (age 23-65 years, 24 males, and 18 females), 50 cases of nor- mal people (age 20-68 years old, male 29, female 21). The differences of age and sex ratio in two groups have no statistically significance. We asked the subjects to hold breath 25s after breath 5-10 minutes. We recorded average flow velocity Vm of MCA and pt, lsatility index PI respectively before and after breath hold, then we calculated the change value and change rate. Results: The average blood flow velocity of Vm in Hyper homocysteinemia group increased faster than that in control group (P 〈 0.01). Pulsatility index and resistance index of RI are higher than those in control group (P 〈 0.05). Hyper homocysteinemia group average blood flow velocity of Vm was lower than that in the control group. The difference was statistically significant (P 〈 0.01). Conclusion: The reactivity of Hyper homocysteinemia cerebral vascular reduced. TCD examina- tion can provide theoretical basis for homocysteine early prevention.
出处 《黑龙江医药科学》 2014年第1期32-33,共2页 Heilongjiang Medicine and Pharmacy
关键词 高同型半胱氨酸血症 脑血管反应性 经颅多普勒 屏气试验 high homocysteine cerebrovascular reactivity transcranial doppler breath holding test
  • 相关文献

参考文献11

  • 1华智强,王滨,张剑平,程卫国.短暂性脑缺血发作的临床、MR I和TCD表现分析[J].黑龙江医药科学,2005,28(6):64-65. 被引量:2
  • 2许晓燕,解云萍,刘俊英.TCD对早期颅内血管狭窄的诊断意义[J].黑龙江医药科学,2010,33(3):61-61. 被引量:4
  • 3Ling Q. Inhibition of endothelial cell thromboresistance by homocysteine[J].J Nula,2000.373-376.
  • 4Midorikawa S,SanadaH,Hashimoto S. Enhancement by homocysteine afplasminogen activatorinhibitor-1 gene expression and secretion from ascular endothe8 andsmooth muscle ells[J].Bioehembiophys Rescommun,2000,(01):182-185.
  • 5Brunelli T,Prisco D,Fedi S. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm[J].JVase Surg,2000,(03):531-553.
  • 6王兴祥,尚云鹏,朱军慧,陈君柱,朱建华,陶谦民,郭晓纲,王战坤,张力.同型半胱氨酸对外周血内皮祖细胞数量和功能的影响[J].中国病理生理杂志,2005,21(7):1274-1278. 被引量:11
  • 7Hieronim J. Protein homocysteinylation:possible mechanism underlyingpathologicakonsequencesofelevatedhomocysteinelevels[J].FA-SEBJ,1999.2277-2283.
  • 8Chambers JC,Obeid OA. Physiological increments in plasma homocysteine inducevascular endothelial dysfunction in normal human subjects[J].Arterioscler ThmmbVasc Biol,1999,(12):2922-2927.
  • 9PavicsL,Grunwald F,Barzo P. Eval uation of cerebral vaso reactivity by SPECT and transcranial Dopplers onography using theacetaz ola mide test[J].Nuklear Medizin,1994,(05):239-243.
  • 10Lee JH,Kelly DF,Oertel M. Carbon dioxide eactivity,perssue autoregulation,and metabolic suppression reactivity after head injury:a transcranial Doppler study[J].J Nearosury,2001,(02):222-232.

二级参考文献23

  • 1黄春霞,许永成,苏兰花.经颅多普勒超声对166例短暂性脑缺血发作的检测分析[J].广西医学,1995,17(6):496-497. 被引量:2
  • 2范常锋,黄一宁.2711例社区居民脑血管狭窄的流行病学调查[J].中华老年心脑血管病杂志,2007,9(1):36-38. 被引量:53
  • 3中华神经科学会 中华神经外科学会.脑血管疾病分类(1995)[J].中华神经科杂志,1996,29(3):233-235.
  • 4Suh DC, Lee SH, Kim KR, et al. Pattern of atherosclerotie carotid stenosis in Korean patients with stroke ;different involvement of intraeranial versus extraeranial vessels[J]. Am J Neuroradiol, 2003,24 (2) :239-244.
  • 5Rother J, Sehwartz A, Wntz KU, et al. Middle cerebral artery stenose : assessment by magnetic resonance angiography and Transcranial Doppler ultrasound [J]. Cerebrovasc Dis, 1994,41273-279.
  • 6黄一宁,高山,王莉鹃,汪波.闭塞性脑血管病经颅多谱勒超声和脑血管造影的比较[J].中华神经科杂志,1997,30(2):98-101. 被引量:176
  • 7Woo KS, Qiao M, Chook P, et al. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention[J]. J Card Surg, 2002, 17(5): 432 -435.
  • 8Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk[J]. N Engl J Med, 2003, 348(7): 593- 600.
  • 9Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow - derived endothelial progenitor cells [ J ]. Circulation, 2002, 105 (25): 3017 -3024.
  • 10Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expranded endothelial progenitor cells for therapeutic neovascularization[ J]. Proc Natl Acad Sci USA, 2000, 97(7): 3422 - 3427.

共引文献14

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部